about
Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine usersHypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefitHypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA.Cohort study of the association of hypnotic use with mortality in postmenopausal women.Benzodiazepines and risk of all cause mortality in adults: cohort studyComparative efficacy of two primary care interventions to assist withdrawal from long term benzodiazepine use: a protocol for a clustered, randomized clinical trial.Association of hypnotics with stroke risk: a population-based case-control study.Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort studyTreatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression.Over-the-counter and prescription sleep medication and incident stroke: the REasons for Geographic and Racial Differences in Stroke study.Hypnotics' association with mortality or cancer: a matched cohort study.Hypnotics and mortality in an elderly general population: a 12-year prospective study.Sitting and television viewing: novel risk factors for sleep disturbance and apnea risk? results from the 2013 National Sleep Foundation Sleep in America Poll.The Use of Hypnotics and Mortality--A Population-Based Retrospective Cohort Study.Multimorbidity and use of hypnotic and anxiolytic drugs: cross-sectional and follow-up study in primary healthcare in Iceland.Sleep disturbances and suicidality: a common association to look for in clinical practise and preventive care.Mortality and use of psychotropic medication in patients with stroke: a population-wide, register-based studyThe association between insomnia and cardiovascular diseasesA nine-year follow-up study of sleep patterns and mortality in community-dwelling older adults in TaiwanSleep in dementia and caregiving--assessment and treatment implications: a review.Mortality Risk of Hypnotics: Strengths and Limits of Evidence.Mortality associated with anxiolytic and hypnotic drugs-A systematic review and meta-analysis.Is suvorexant a better choice than alternative hypnotics?Association between hypnotics use and increased mortality: causation or confounding?Hypnotics and mortality--partial confounding by disease, substance abuse and socioeconomic factors?Insomnia, hypnotic drug use, and patient well-being: first, do no harm.Suicidality in sleep disorders: prevalence, impact, and management strategiesSurprising view of insomnia and sleeping pills.Use of hypnotics and the risk of or mortality from heart disease: a meta-analysis of observational studies.Influence of zolpidem and sleep inertia on balance and cognition during nighttime awakening: a randomized placebo-controlled trial.
P2860
Q24186909-679EFEE6-6A77-43C5-89C9-E7CCFADD38C1Q26745934-02D85693-4E38-41FD-A72D-51BF1F1FAF14Q30245527-A4C17547-BC9C-4B78-ACEA-3D77F0007A82Q30525579-11233A1D-EAFC-4431-910A-67ED79A3F6ECQ33877600-1B3C4B94-DB95-4A4F-AC8E-123E594218F9Q33877955-B7CDE429-9B0D-4D93-96B0-8EAEAE7554BDQ33975826-4042DF6E-213A-4743-8010-6C31763D23A9Q34040228-E0D3D05A-27B2-459C-94BF-226C946A4667Q34058141-C3F46788-F7D8-4A9B-B7D0-FD54BD52D459Q34150449-0AABE47D-AE07-4ED9-AFAA-5CC73361768DQ34257362-D32CAB01-DB87-4C21-B180-7FF3A2D29D10Q35000200-5CE48BD3-3F91-41AC-8FEE-EDB62F0F1410Q35190281-648BC934-D0C1-4BD4-AC13-C9C653603B8BQ35879540-DB9AFE51-3CE5-4501-9455-88A426528D92Q36042579-60D3F3A8-10D7-4A5C-B5F5-C7F575661391Q36117945-7EAD50DA-D182-4454-859D-02C8A58E5A09Q36670523-24D11CD3-E5A8-4C4A-AD75-00E23293ABE5Q36779786-24B7BF0D-CD25-4000-ADFE-F2FFC4E3CE69Q36980424-DD267A29-73ED-452F-9F9E-2DEC7462355AQ37800192-3B4AE778-FC96-468A-B5F5-AEC5D7D22678Q38631980-8007097D-180F-49CC-855E-61B2F868398DQ38641304-A2E1EDCC-57C6-41F1-8FB2-E71902F5DBEDQ40900071-7F3AD777-0BF1-401D-BCD4-6F4C45174017Q41111610-4DE1794B-AA0C-48B1-A57D-3C5B4C984714Q41399476-076FC3BC-56A1-4068-A971-6C3567F4EF89Q42336107-DF40C368-6C05-4D75-9CDF-5587CEE8A29CQ42731638-06E4193D-2524-45C6-BF17-D8281DDAD1D7Q43107028-E0429051-7E2D-47C8-AA89-0CC08C99B520Q47692944-41D0343A-1A57-4085-B1E2-D9AAD0E3C9FFQ48321792-47FCDEFB-8DE8-49B4-B864-550AF4830B0D
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Is usage of hypnotics associated with mortality?
@ast
Is usage of hypnotics associated with mortality?
@en
Is usage of hypnotics associated with mortality?
@nl
type
label
Is usage of hypnotics associated with mortality?
@ast
Is usage of hypnotics associated with mortality?
@en
Is usage of hypnotics associated with mortality?
@nl
prefLabel
Is usage of hypnotics associated with mortality?
@ast
Is usage of hypnotics associated with mortality?
@en
Is usage of hypnotics associated with mortality?
@nl
P2093
P1433
P1476
Is usage of hypnotics associated with mortality?
@en
P2093
Jan-Erik Broman
Jerker Hetta
Lena Mallon
P304
P356
10.1016/J.SLEEP.2008.12.004
P577
2009-03-09T00:00:00Z